Caprock Group LLC Buys New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Caprock Group LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 11,557 shares of the pharmacy operator’s stock, valued at approximately $108,000.

Other hedge funds have also added to or reduced their stakes in the company. First Financial Corp IN lifted its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the period. TD Private Client Wealth LLC lifted its position in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the period. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Eastern Bank purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth about $33,000. Finally, Brooklyn Investment Group bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth about $35,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on WBA. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. UBS Group upped their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Jefferies Financial Group cut their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Finally, Barclays lifted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.19.

Walgreens Boots Alliance Stock Up 0.7 %

WBA opened at $10.12 on Friday. The stock has a market capitalization of $8.75 billion, a price-to-earnings ratio of -0.99, a PEG ratio of 1.28 and a beta of 0.65. The firm has a 50 day moving average price of $10.20 and a 200-day moving average price of $9.83. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.96. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.66 EPS. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.